Pharmacopsychiatry 2017; 50(06): 270
DOI: 10.1055/s-0043-109240
Letter to the Editor
© Georg Thieme Verlag KG Stuttgart · New York

New Onset of Suicidal Impulses Following Abrupt Cessation of Valproate

Johannes Ladwig
1   Klinik für Psychiatrie, Medizinische Hochschule Hannover, Sozialpsychiatrie und Psychotherapie, Hannover, Germany
,
Dorothea Andreae
2   Department of Psychiatry, Psychotherapy and Psychosomatics, Asklepios Fachklinikum Teupitz, Teupitz, Germany
,
Renate Grohmann
3   Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universitat Munchen, Munchen, Bayern, Germany
,
Sermin Toto
4   Department of Psychiatry, Social Psychiatry and Psychotherapy, Medizinische Hochschule Hannover, Hannover, Germany
,
Stefan Kropp
2   Department of Psychiatry, Psychotherapy and Psychosomatics, Asklepios Fachklinikum Teupitz, Teupitz, Germany
,
Stefan Bleich
1   Klinik für Psychiatrie, Medizinische Hochschule Hannover, Sozialpsychiatrie und Psychotherapie, Hannover, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
08. Mai 2017 (online)

 
  • References

  • 1 Hawton K, Sutton L, Haw C. et al. Suicide and attempted suicide in bipolar disorder: A systematic review of risk factors. J Clin Psychiatry 2005; 66: 693-704
  • 2 FDA CDER. Statistical review and evaluation. Antiepileptic drugs and suicidality. http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf 2008;
  • 3 Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. J Affect Disord 2007; 103: 5-11
  • 4 Engel RR, Grohmann R, Rüther E. et al. Research methods in drug surveillance. Pharmacopsychiatry 2004; 37: S12-S15
  • 5 Grohmann R, Engel RR, Rüther E. et al. The AMSP drug safety program: Methods and global results. Pharmacopsychiatry 2004; 37 (Suppl. 01) S4-11